nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MTR—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0216	0.118	CbGpPWpGaD
Hydroxocobalamin—TCN2—seminal vesicle—testicular cancer	0.0188	0.0598	CbGeAlD
Hydroxocobalamin—MUT—seminal vesicle—testicular cancer	0.0148	0.0471	CbGeAlD
Hydroxocobalamin—AMN—testis—testicular cancer	0.0144	0.0458	CbGeAlD
Hydroxocobalamin—CUBN—female gonad—testicular cancer	0.0137	0.0434	CbGeAlD
Hydroxocobalamin—MTRR—seminal vesicle—testicular cancer	0.0133	0.0423	CbGeAlD
Hydroxocobalamin—MMAA—female gonad—testicular cancer	0.0129	0.0411	CbGeAlD
Hydroxocobalamin—CUBN—testis—testicular cancer	0.0121	0.0385	CbGeAlD
Hydroxocobalamin—MMAB—female gonad—testicular cancer	0.0121	0.0385	CbGeAlD
Hydroxocobalamin—MTR—seminal vesicle—testicular cancer	0.0116	0.0369	CbGeAlD
Hydroxocobalamin—MMAA—testis—testicular cancer	0.0115	0.0364	CbGeAlD
Hydroxocobalamin—CASP9—female gonad—testicular cancer	0.0113	0.036	CbGeAlD
Hydroxocobalamin—MMAB—testis—testicular cancer	0.0108	0.0342	CbGeAlD
Hydroxocobalamin—MUT—gonad—testicular cancer	0.0107	0.034	CbGeAlD
Hydroxocobalamin—AMN—lymph node—testicular cancer	0.0104	0.0332	CbGeAlD
Hydroxocobalamin—CASP9—testis—testicular cancer	0.01	0.0319	CbGeAlD
Hydroxocobalamin—TCN2—testis—testicular cancer	0.00981	0.0312	CbGeAlD
Hydroxocobalamin—MTRR—gonad—testicular cancer	0.00962	0.0306	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—testicular cancer	0.00879	0.0279	CbGeAlD
Hydroxocobalamin—MUT—female gonad—testicular cancer	0.0087	0.0276	CbGeAlD
Hydroxocobalamin—MTR—gonad—testicular cancer	0.00839	0.0267	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—testicular cancer	0.00831	0.0264	CbGeAlD
Hydroxocobalamin—MTRR—female gonad—testicular cancer	0.00781	0.0248	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—testicular cancer	0.0078	0.0248	CbGeAlD
Hydroxocobalamin—MUT—testis—testicular cancer	0.00771	0.0245	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—testicular cancer	0.00728	0.0231	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—testicular cancer	0.00711	0.0226	CbGeAlD
Hydroxocobalamin—MTRR—testis—testicular cancer	0.00693	0.022	CbGeAlD
Hydroxocobalamin—MTR—female gonad—testicular cancer	0.00682	0.0217	CbGeAlD
Hydroxocobalamin—MTR—testis—testicular cancer	0.00604	0.0192	CbGeAlD
Hydroxocobalamin—MTRR—Phase II conjugation—HPGDS—testicular cancer	0.00565	0.0309	CbGpPWpGaD
Hydroxocobalamin—MUT—lymph node—testicular cancer	0.00559	0.0178	CbGeAlD
Hydroxocobalamin—MTRR—lymph node—testicular cancer	0.00502	0.016	CbGeAlD
Hydroxocobalamin—MTR—Phase II conjugation—HPGDS—testicular cancer	0.0046	0.0252	CbGpPWpGaD
Hydroxocobalamin—MTR—lymph node—testicular cancer	0.00438	0.0139	CbGeAlD
Hydroxocobalamin—MTRR—Biological oxidations—HPGDS—testicular cancer	0.0033	0.0181	CbGpPWpGaD
Hydroxocobalamin—MTR—Biological oxidations—HPGDS—testicular cancer	0.00269	0.0147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—KITLG—testicular cancer	0.00237	0.013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.00231	0.0127	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.00221	0.0121	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI-3K cascade—KITLG—testicular cancer	0.00214	0.0117	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—KITLG—testicular cancer	0.00209	0.0114	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—KITLG—testicular cancer	0.00207	0.0113	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—BCL10—testicular cancer	0.00204	0.0112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—KITLG—testicular cancer	0.00202	0.0111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.00186	0.0102	CbGpPWpGaD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—MMP2—testicular cancer	0.00177	0.0097	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—testicular cancer	0.00176	0.00964	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00175	0.00959	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00175	0.00959	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00167	0.00915	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.00163	0.00894	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—KIT—testicular cancer	0.00162	0.00885	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—KITLG—testicular cancer	0.0016	0.00874	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI-3K cascade—FGFR3—testicular cancer	0.00159	0.00869	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—FGFR3—testicular cancer	0.00155	0.00848	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00154	0.00845	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—FGFR3—testicular cancer	0.00154	0.00841	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.00153	0.00836	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—KITLG—testicular cancer	0.0015	0.00823	CbGpPWpGaD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—testicular cancer	0.0015	0.00822	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI-3K cascade—KIT—testicular cancer	0.00146	0.00798	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—KITLG—testicular cancer	0.00144	0.00786	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—KITLG—testicular cancer	0.00143	0.00782	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—KIT—testicular cancer	0.00142	0.00779	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—KITLG—testicular cancer	0.00142	0.00778	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—KITLG—testicular cancer	0.00142	0.00774	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—KIT—testicular cancer	0.00141	0.00772	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.0014	0.00763	CbGpPWpGaD
Hydroxocobalamin—Oedema—Bleomycin—testicular cancer	0.00139	0.00277	CcSEcCtD
Hydroxocobalamin—Infection—Bleomycin—testicular cancer	0.00138	0.00275	CcSEcCtD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—testicular cancer	0.00138	0.00755	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Vinblastine—testicular cancer	0.00136	0.0027	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—testicular cancer	0.00136	0.0027	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.00135	0.00741	CbGpPWpGaD
Hydroxocobalamin—Ill-defined disorder—Ifosfamide—testicular cancer	0.00135	0.00269	CcSEcCtD
Hydroxocobalamin—Eye disorder—Cisplatin—testicular cancer	0.00135	0.00269	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Cisplatin—testicular cancer	0.00134	0.00267	CcSEcCtD
Hydroxocobalamin—Agitation—Ifosfamide—testicular cancer	0.00134	0.00267	CcSEcCtD
Hydroxocobalamin—Discomfort—Dactinomycin—testicular cancer	0.00134	0.00266	CcSEcCtD
Hydroxocobalamin—Angioedema—Ifosfamide—testicular cancer	0.00133	0.00265	CcSEcCtD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.00133	0.00728	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KITLG—testicular cancer	0.00133	0.00728	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—KITLG—testicular cancer	0.00133	0.00728	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Chlorambucil—testicular cancer	0.00133	0.00264	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—KITLG—testicular cancer	0.00132	0.00722	CbGpPWpGaD
Hydroxocobalamin—Malaise—Ifosfamide—testicular cancer	0.00131	0.00262	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—testicular cancer	0.00131	0.00262	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.00131	0.00715	CbGpPWpGaD
Hydroxocobalamin—Urinary tract disorder—Etoposide—testicular cancer	0.00131	0.0026	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Cisplatin—testicular cancer	0.0013	0.0026	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by PDGF—KITLG—testicular cancer	0.0013	0.00712	CbGpPWpGaD
Hydroxocobalamin—Mediastinal disorder—Cisplatin—testicular cancer	0.0013	0.00259	CcSEcCtD
Hydroxocobalamin—Oedema—Dactinomycin—testicular cancer	0.0013	0.00258	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Etoposide—testicular cancer	0.0013	0.00258	CcSEcCtD
Hydroxocobalamin—Infection—Dactinomycin—testicular cancer	0.00129	0.00257	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Cisplatin—testicular cancer	0.00129	0.00257	CcSEcCtD
Hydroxocobalamin—Pruritus—Chlorambucil—testicular cancer	0.00127	0.00253	CcSEcCtD
Hydroxocobalamin—Erythema—Cisplatin—testicular cancer	0.00126	0.0025	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—testicular cancer	0.00124	0.00248	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Bleomycin—testicular cancer	0.00124	0.00247	CcSEcCtD
Hydroxocobalamin—Chest pain—Ifosfamide—testicular cancer	0.00124	0.00247	CcSEcCtD
Hydroxocobalamin—Eye disorder—Etoposide—testicular cancer	0.00124	0.00246	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00123	0.00245	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—KITLG—testicular cancer	0.00123	0.00674	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Chlorambucil—testicular cancer	0.00123	0.00245	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Etoposide—testicular cancer	0.00123	0.00244	CcSEcCtD
Hydroxocobalamin—Discomfort—Ifosfamide—testicular cancer	0.00123	0.00244	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—testicular cancer	0.00122	0.00242	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vinblastine—testicular cancer	0.00121	0.00242	CcSEcCtD
Hydroxocobalamin—Angiopathy—Etoposide—testicular cancer	0.0012	0.00239	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Etoposide—testicular cancer	0.00119	0.00238	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—testicular cancer	0.00119	0.00237	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Etoposide—testicular cancer	0.00119	0.00237	CcSEcCtD
Hydroxocobalamin—Pain—Bleomycin—testicular cancer	0.00119	0.00237	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Ifosfamide—testicular cancer	0.00119	0.00237	CcSEcCtD
Hydroxocobalamin—Oedema—Ifosfamide—testicular cancer	0.00119	0.00237	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—FGFR3—testicular cancer	0.00119	0.00649	CbGpPWpGaD
Hydroxocobalamin—Chills—Etoposide—testicular cancer	0.00119	0.00236	CcSEcCtD
Hydroxocobalamin—Infection—Ifosfamide—testicular cancer	0.00118	0.00235	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—testicular cancer	0.00118	0.00235	CcSEcCtD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00118	0.00645	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Ifosfamide—testicular cancer	0.00117	0.00232	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Cisplatin—testicular cancer	0.00117	0.00232	CcSEcCtD
Hydroxocobalamin—Skin disorder—Ifosfamide—testicular cancer	0.00116	0.0023	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—testicular cancer	0.00115	0.00229	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Bleomycin—testicular cancer	0.00115	0.00228	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—testicular cancer	0.00115	0.00228	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.00114	0.00621	CbGpPWpGaD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—testicular cancer	0.00114	0.00226	CcSEcCtD
Hydroxocobalamin—Malaise—Cisplatin—testicular cancer	0.00113	0.00226	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vinblastine—testicular cancer	0.00113	0.00224	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—testicular cancer	0.00112	0.00223	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB4—FGFR3—testicular cancer	0.00112	0.00611	CbGpPWpGaD
Hydroxocobalamin—Pain—Dactinomycin—testicular cancer	0.00111	0.00221	CcSEcCtD
Hydroxocobalamin—Urticaria—Bleomycin—testicular cancer	0.00111	0.0022	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—testicular cancer	0.0011	0.0022	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Bleomycin—testicular cancer	0.0011	0.00219	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00109	0.00218	CcSEcCtD
Hydroxocobalamin—Dizziness—Vinblastine—testicular cancer	0.00109	0.00217	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—KIT—testicular cancer	0.00109	0.00596	CbGpPWpGaD
Hydroxocobalamin—Hyponatraemia—Epirubicin—testicular cancer	0.00108	0.00214	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dactinomycin—testicular cancer	0.00107	0.00213	CcSEcCtD
Hydroxocobalamin—Nausea—Chlorambucil—testicular cancer	0.00107	0.00213	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Etoposide—testicular cancer	0.00107	0.00213	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—FGFR3—testicular cancer	0.00107	0.00584	CbGpPWpGaD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00106	0.00211	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by FGFR—FGFR3—testicular cancer	0.00106	0.00581	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Ifosfamide—testicular cancer	0.00106	0.00211	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—testicular cancer	0.00106	0.00211	CcSEcCtD
Hydroxocobalamin—Discomfort—Cisplatin—testicular cancer	0.00106	0.0021	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB2—FGFR3—testicular cancer	0.00106	0.00578	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—FGFR3—testicular cancer	0.00105	0.00575	CbGpPWpGaD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—testicular cancer	0.00105	0.00209	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—KIT—testicular cancer	0.00104	0.0057	CbGpPWpGaD
Hydroxocobalamin—Malaise—Etoposide—testicular cancer	0.00104	0.00207	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—testicular cancer	0.00104	0.00207	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.00104	0.00567	CbGpPWpGaD
Hydroxocobalamin—Headache—Vinblastine—testicular cancer	0.00103	0.00206	CcSEcCtD
Hydroxocobalamin—MMACHC—Metabolism—HPGDS—testicular cancer	0.00103	0.00564	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00103	0.00204	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dactinomycin—testicular cancer	0.00103	0.00204	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB4—KIT—testicular cancer	0.00103	0.00561	CbGpPWpGaD
Hydroxocobalamin—Oedema—Cisplatin—testicular cancer	0.00103	0.00204	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Cisplatin—testicular cancer	0.00103	0.00204	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Bleomycin—testicular cancer	0.00103	0.00204	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—testicular cancer	0.00102	0.00203	CcSEcCtD
Hydroxocobalamin—Infection—Cisplatin—testicular cancer	0.00102	0.00203	CcSEcCtD
Hydroxocobalamin—Pain—Ifosfamide—testicular cancer	0.00102	0.00203	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Cisplatin—testicular cancer	0.00101	0.002	CcSEcCtD
Hydroxocobalamin—Tachycardia—Cisplatin—testicular cancer	0.001	0.00199	CcSEcCtD
Hydroxocobalamin—Skin disorder—Cisplatin—testicular cancer	0.000996	0.00198	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—testicular cancer	0.000996	0.00198	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 interactions—FGFR3—testicular cancer	0.00099	0.00541	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—FGFR3—testicular cancer	0.00099	0.00541	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.00099	0.00541	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Bleomycin—testicular cancer	0.000985	0.00196	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—FGFR3—testicular cancer	0.000981	0.00537	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Ifosfamide—testicular cancer	0.000981	0.00195	CcSEcCtD
Hydroxocobalamin—Chest pain—Etoposide—testicular cancer	0.00098	0.00195	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—KIT—testicular cancer	0.00098	0.00536	CbGpPWpGaD
Hydroxocobalamin—Nausea—Vinblastine—testicular cancer	0.000979	0.00195	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—testicular cancer	0.000975	0.00194	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by FGFR—KIT—testicular cancer	0.000975	0.00534	CbGpPWpGaD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000974	0.00194	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000972	0.00532	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—KIT—testicular cancer	0.000971	0.00531	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Etoposide—testicular cancer	0.000969	0.00193	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by PDGF—FGFR3—testicular cancer	0.000968	0.00529	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—KIT—testicular cancer	0.000966	0.00528	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Dactinomycin—testicular cancer	0.000957	0.0019	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000952	0.00521	CbGpPWpGaD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—testicular cancer	0.000949	0.00189	CcSEcCtD
Hydroxocobalamin—Urticaria—Ifosfamide—testicular cancer	0.000945	0.00188	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—testicular cancer	0.000943	0.00188	CcSEcCtD
Hydroxocobalamin—MMAB—Metabolism—HPGDS—testicular cancer	0.000943	0.00516	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—HPGDS—testicular cancer	0.000943	0.00516	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Ifosfamide—testicular cancer	0.000941	0.00187	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Etoposide—testicular cancer	0.00094	0.00187	CcSEcCtD
Hydroxocobalamin—Infection—Etoposide—testicular cancer	0.000934	0.00186	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—testicular cancer	0.000926	0.00184	CcSEcCtD
Hydroxocobalamin—Tachycardia—Etoposide—testicular cancer	0.000917	0.00183	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—FGFR3—testicular cancer	0.000916	0.00501	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Cisplatin—testicular cancer	0.000915	0.00182	CcSEcCtD
Hydroxocobalamin—Skin disorder—Etoposide—testicular cancer	0.000913	0.00182	CcSEcCtD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000909	0.00497	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—KIT—testicular cancer	0.000909	0.00497	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KIT—testicular cancer	0.000909	0.00497	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KITLG—testicular cancer	0.000907	0.00496	CbGpPWpGaD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—testicular cancer	0.000903	0.0018	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—KIT—testicular cancer	0.000901	0.00493	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—H2AFZ—testicular cancer	0.000899	0.00492	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000893	0.00488	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—KIT—testicular cancer	0.000889	0.00486	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Dactinomycin—testicular cancer	0.000888	0.00177	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000886	0.00176	CcSEcCtD
Hydroxocobalamin—Rash—Bleomycin—testicular cancer	0.000878	0.00175	CcSEcCtD
Hydroxocobalamin—Pain—Cisplatin—testicular cancer	0.000877	0.00175	CcSEcCtD
Hydroxocobalamin—Dermatitis—Bleomycin—testicular cancer	0.000877	0.00175	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Ifosfamide—testicular cancer	0.000877	0.00174	CcSEcCtD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000877	0.00479	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—HPGDS—testicular cancer	0.000876	0.00479	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—BCL10—testicular cancer	0.000858	0.00469	CbGpPWpGaD
Hydroxocobalamin—Dysphagia—Doxorubicin—testicular cancer	0.000857	0.00171	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Cisplatin—testicular cancer	0.000845	0.00168	CcSEcCtD
Hydroxocobalamin—Pruritus—Ifosfamide—testicular cancer	0.000842	0.00168	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—KIT—testicular cancer	0.000841	0.0046	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Etoposide—testicular cancer	0.000838	0.00167	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—KITLG—testicular cancer	0.000827	0.00453	CbGpPWpGaD
Hydroxocobalamin—Nausea—Bleomycin—testicular cancer	0.000827	0.00165	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—BCL10—testicular cancer	0.000824	0.00451	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—H2AFZ—testicular cancer	0.000823	0.0045	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—H2AFZ—testicular cancer	0.000823	0.0045	CbGpPWpGaD
Hydroxocobalamin—Rash—Dactinomycin—testicular cancer	0.000819	0.00163	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Ifosfamide—testicular cancer	0.000814	0.00162	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000811	0.00161	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Cisplatin—testicular cancer	0.000811	0.00161	CcSEcCtD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000805	0.0044	CbGpPWpGaD
Hydroxocobalamin—Pain—Etoposide—testicular cancer	0.000804	0.0016	CcSEcCtD
Hydroxocobalamin—Dizziness—Ifosfamide—testicular cancer	0.000787	0.00157	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—testicular cancer	0.000783	0.00156	CcSEcCtD
Hydroxocobalamin—MMAA—Metabolism—HPGDS—testicular cancer	0.000781	0.00427	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—HPGDS—testicular cancer	0.000781	0.00427	CbGpPWpGaD
Hydroxocobalamin—Urethral disorder—Methotrexate—testicular cancer	0.000777	0.00155	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Etoposide—testicular cancer	0.000774	0.00154	CcSEcCtD
Hydroxocobalamin—Nausea—Dactinomycin—testicular cancer	0.000771	0.00153	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—H2AFZ—testicular cancer	0.000765	0.00418	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KITLG—testicular cancer	0.000757	0.00414	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KITLG—testicular cancer	0.000757	0.00414	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Cisplatin—testicular cancer	0.000756	0.0015	CcSEcCtD
Hydroxocobalamin—Rash—Ifosfamide—testicular cancer	0.00075	0.00149	CcSEcCtD
Hydroxocobalamin—Dermatitis—Ifosfamide—testicular cancer	0.00075	0.00149	CcSEcCtD
Hydroxocobalamin—MMACHC—Metabolism—STK11—testicular cancer	0.000749	0.0041	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Etoposide—testicular cancer	0.000747	0.00149	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—HPGDS—testicular cancer	0.000745	0.00408	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Etoposide—testicular cancer	0.000743	0.00148	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—testicular cancer	0.00074	0.00147	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—testicular cancer	0.000735	0.00146	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—testicular cancer	0.000732	0.00146	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—testicular cancer	0.00073	0.00145	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—testicular cancer	0.000727	0.00145	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—testicular cancer	0.000719	0.00143	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—testicular cancer	0.000716	0.00142	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—testicular cancer	0.000714	0.00142	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—testicular cancer	0.000711	0.00141	CcSEcCtD
Hydroxocobalamin—Nausea—Ifosfamide—testicular cancer	0.000707	0.00141	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—KITLG—testicular cancer	0.000704	0.00385	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Cisplatin—testicular cancer	0.000702	0.0014	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—testicular cancer	0.000694	0.00138	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—testicular cancer	0.000693	0.00138	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Etoposide—testicular cancer	0.000692	0.00138	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—testicular cancer	0.00069	0.00137	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—testicular cancer	0.000688	0.00137	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—HPGDS—testicular cancer	0.000688	0.00376	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—STK11—testicular cancer	0.000685	0.00375	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—STK11—testicular cancer	0.000685	0.00375	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—H2AFZ—testicular cancer	0.000682	0.00373	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—H2AFZ—testicular cancer	0.000682	0.00373	CbGpPWpGaD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—testicular cancer	0.000678	0.00135	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—testicular cancer	0.000676	0.00135	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by NGF—FGFR3—testicular cancer	0.000674	0.00369	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Epirubicin—testicular cancer	0.000673	0.00134	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—testicular cancer	0.000673	0.00134	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—testicular cancer	0.00067	0.00133	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—testicular cancer	0.000668	0.00133	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—testicular cancer	0.000665	0.00132	CcSEcCtD
Hydroxocobalamin—Pruritus—Etoposide—testicular cancer	0.000665	0.00132	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—testicular cancer	0.000662	0.00132	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling Pathways—INSL3—testicular cancer	0.000662	0.00362	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—H2AFZ—testicular cancer	0.00065	0.00356	CbGpPWpGaD
Hydroxocobalamin—Mental disorder—Epirubicin—testicular cancer	0.00065	0.00129	CcSEcCtD
Hydroxocobalamin—Rash—Cisplatin—testicular cancer	0.000647	0.00129	CcSEcCtD
Hydroxocobalamin—Dermatitis—Cisplatin—testicular cancer	0.000646	0.00129	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—testicular cancer	0.000645	0.00128	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Etoposide—testicular cancer	0.000643	0.00128	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—testicular cancer	0.000641	0.00128	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—testicular cancer	0.00064	0.00127	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—STK11—testicular cancer	0.000637	0.00348	CbGpPWpGaD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—testicular cancer	0.000637	0.00127	CcSEcCtD
Hydroxocobalamin—AMN—Disease—KITLG—testicular cancer	0.000627	0.00343	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KITLG—testicular cancer	0.000627	0.00343	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Doxorubicin—testicular cancer	0.000622	0.00124	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—testicular cancer	0.000622	0.00124	CcSEcCtD
Hydroxocobalamin—Dizziness—Etoposide—testicular cancer	0.000621	0.00124	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—testicular cancer	0.00062	0.00123	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by NGF—KIT—testicular cancer	0.000619	0.00339	CbGpPWpGaD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000618	0.00123	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—testicular cancer	0.000616	0.00123	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—FGFR3—testicular cancer	0.000615	0.00336	CbGpPWpGaD
Hydroxocobalamin—Arrhythmia—Doxorubicin—testicular cancer	0.000613	0.00122	CcSEcCtD
Hydroxocobalamin—Nausea—Cisplatin—testicular cancer	0.000609	0.00121	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—testicular cancer	0.000601	0.0012	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—H2AFZ—testicular cancer	0.0006	0.00328	CbGpPWpGaD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—testicular cancer	0.000599	0.00119	CcSEcCtD
Hydroxocobalamin—MUT—Disease—KITLG—testicular cancer	0.000598	0.00327	CbGpPWpGaD
Hydroxocobalamin—Erythema—Doxorubicin—testicular cancer	0.000597	0.00119	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—testicular cancer	0.000593	0.00118	CcSEcCtD
Hydroxocobalamin—Rash—Etoposide—testicular cancer	0.000593	0.00118	CcSEcCtD
Hydroxocobalamin—Dermatitis—Etoposide—testicular cancer	0.000592	0.00118	CcSEcCtD
Hydroxocobalamin—Headache—Etoposide—testicular cancer	0.000589	0.00117	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—testicular cancer	0.000587	0.00117	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000583	0.00116	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—testicular cancer	0.000582	0.00116	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—testicular cancer	0.00058	0.00115	CcSEcCtD
Hydroxocobalamin—MMAA—Metabolism—STK11—testicular cancer	0.000568	0.0031	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—STK11—testicular cancer	0.000568	0.0031	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—HPGDS—testicular cancer	0.000565	0.00309	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KIT—testicular cancer	0.000565	0.00309	CbGpPWpGaD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—testicular cancer	0.000563	0.00112	CcSEcCtD
Hydroxocobalamin—MMAB—Disease—FGFR3—testicular cancer	0.000562	0.00308	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—FGFR3—testicular cancer	0.000562	0.00308	CbGpPWpGaD
Hydroxocobalamin—Infection—Methotrexate—testicular cancer	0.000559	0.00111	CcSEcCtD
Hydroxocobalamin—Nausea—Etoposide—testicular cancer	0.000558	0.00111	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000554	0.0011	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—KITLG—testicular cancer	0.000552	0.00302	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Methotrexate—testicular cancer	0.000552	0.0011	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—testicular cancer	0.00055	0.00109	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—testicular cancer	0.000549	0.00109	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—testicular cancer	0.000547	0.00109	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000546	0.00109	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—testicular cancer	0.000543	0.00108	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—STK11—testicular cancer	0.000541	0.00296	CbGpPWpGaD
Hydroxocobalamin—Malaise—Doxorubicin—testicular cancer	0.000539	0.00107	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—testicular cancer	0.000527	0.00105	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—testicular cancer	0.000527	0.00105	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—testicular cancer	0.000523	0.00104	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—FGFR3—testicular cancer	0.000523	0.00286	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KITLG—testicular cancer	0.000517	0.00283	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Epirubicin—testicular cancer	0.000517	0.00103	CcSEcCtD
Hydroxocobalamin—MMAB—Disease—KIT—testicular cancer	0.000516	0.00282	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KIT—testicular cancer	0.000516	0.00282	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Epirubicin—testicular cancer	0.000514	0.00102	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—testicular cancer	0.000512	0.00102	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—testicular cancer	0.000508	0.00101	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000505	0.001	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—testicular cancer	0.000502	0.001	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Methotrexate—testicular cancer	0.000502	0.000999	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—BCL10—testicular cancer	0.0005	0.00273	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—STK11—testicular cancer	0.0005	0.00273	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KITLG—testicular cancer	0.000497	0.00272	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Methotrexate—testicular cancer	0.000496	0.000986	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—H2AFZ—testicular cancer	0.000493	0.0027	CbGpPWpGaD
Hydroxocobalamin—Oedema—Doxorubicin—testicular cancer	0.000487	0.00097	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000487	0.00097	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000486	0.000967	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—testicular cancer	0.000484	0.000964	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—testicular cancer	0.000481	0.000958	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—KIT—testicular cancer	0.00048	0.00263	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—testicular cancer	0.000478	0.000951	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—testicular cancer	0.000476	0.000947	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—testicular cancer	0.000473	0.000942	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—testicular cancer	0.00047	0.000935	CcSEcCtD
Hydroxocobalamin—AMN—Disease—FGFR3—testicular cancer	0.000466	0.00255	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—FGFR3—testicular cancer	0.000466	0.00255	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Methotrexate—testicular cancer	0.000464	0.000923	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—testicular cancer	0.000464	0.000923	CcSEcCtD
Hydroxocobalamin—MTR—Metabolism—HPGDS—testicular cancer	0.00046	0.00252	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000455	0.000905	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—KITLG—testicular cancer	0.000453	0.00248	CbGpPWpGaD
Hydroxocobalamin—Pain—Epirubicin—testicular cancer	0.000451	0.000897	CcSEcCtD
Hydroxocobalamin—Urticaria—Methotrexate—testicular cancer	0.000447	0.00089	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—testicular cancer	0.000445	0.000886	CcSEcCtD
Hydroxocobalamin—MUT—Disease—FGFR3—testicular cancer	0.000445	0.00243	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Doxorubicin—testicular cancer	0.000435	0.000865	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—testicular cancer	0.000434	0.000864	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—testicular cancer	0.000429	0.000854	CcSEcCtD
Hydroxocobalamin—AMN—Disease—KIT—testicular cancer	0.000428	0.00234	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KIT—testicular cancer	0.000428	0.00234	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000421	0.000837	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—testicular cancer	0.000419	0.000833	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—testicular cancer	0.000417	0.00083	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—testicular cancer	0.000416	0.000829	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methotrexate—testicular cancer	0.000415	0.000825	CcSEcCtD
Hydroxocobalamin—MTRR—Metabolism—STK11—testicular cancer	0.00041	0.00224	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—FGFR3—testicular cancer	0.00041	0.00224	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KIT—testicular cancer	0.000408	0.00223	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—H2AFZ—testicular cancer	0.000402	0.0022	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—testicular cancer	0.000402	0.000799	CcSEcCtD
Hydroxocobalamin—Pruritus—Methotrexate—testicular cancer	0.000398	0.000793	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—testicular cancer	0.000388	0.000772	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—testicular cancer	0.000387	0.000771	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—testicular cancer	0.000385	0.000767	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—testicular cancer	0.000385	0.000767	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—FGFR3—testicular cancer	0.000385	0.0021	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KIT—testicular cancer	0.000377	0.00206	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Epirubicin—testicular cancer	0.000373	0.000742	CcSEcCtD
Hydroxocobalamin—Dizziness—Methotrexate—testicular cancer	0.000372	0.000741	CcSEcCtD
Hydroxocobalamin—MTR—Disease—KITLG—testicular cancer	0.00037	0.00202	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—FGFR3—testicular cancer	0.000369	0.00202	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Epirubicin—testicular cancer	0.00036	0.000717	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—testicular cancer	0.000359	0.000715	CcSEcCtD
Hydroxocobalamin—Rash—Methotrexate—testicular cancer	0.000355	0.000706	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—testicular cancer	0.000355	0.000706	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—KIT—testicular cancer	0.000353	0.00193	CbGpPWpGaD
Hydroxocobalamin—Headache—Methotrexate—testicular cancer	0.000353	0.000702	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—testicular cancer	0.000348	0.000693	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—testicular cancer	0.000345	0.000686	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—KIT—testicular cancer	0.000339	0.00185	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FGFR3—testicular cancer	0.000337	0.00184	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—STK11—testicular cancer	0.000335	0.00183	CbGpPWpGaD
Hydroxocobalamin—Nausea—Methotrexate—testicular cancer	0.000334	0.000665	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—testicular cancer	0.000334	0.000664	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—testicular cancer	0.000332	0.000661	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—testicular cancer	0.000332	0.00066	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—testicular cancer	0.00033	0.000657	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—testicular cancer	0.000322	0.000641	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—testicular cancer	0.000313	0.000623	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—KIT—testicular cancer	0.000309	0.00169	CbGpPWpGaD
Hydroxocobalamin—Rash—Doxorubicin—testicular cancer	0.000307	0.000612	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—testicular cancer	0.000307	0.000611	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—testicular cancer	0.000305	0.000608	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—H2AFZ—testicular cancer	0.000302	0.00165	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KITLG—testicular cancer	0.000301	0.00165	CbGpPWpGaD
Hydroxocobalamin—Nausea—Doxorubicin—testicular cancer	0.00029	0.000576	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—KITLG—testicular cancer	0.000278	0.00152	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGFR3—testicular cancer	0.000275	0.0015	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KIT—testicular cancer	0.000252	0.00138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGFR3—testicular cancer	0.000224	0.00123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—H2AFZ—testicular cancer	0.000212	0.00116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STK11—testicular cancer	0.000211	0.00115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGFR3—testicular cancer	0.000207	0.00113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—testicular cancer	0.000206	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KITLG—testicular cancer	0.000195	0.00107	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—testicular cancer	0.00019	0.00104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR3—testicular cancer	0.000145	0.000792	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—testicular cancer	0.000133	0.000727	CbGpPWpGaD
